Cross Country Healthcare (NASDAQ: CCRN) has revised its earnings guidance for the first quarter of 2026, projecting a loss per share of between -0.060 and 0.040. This update comes in contrast to the consensus estimate of a profit of 0.030 per share. The company also anticipates revenue between $235.0 million and $240.0 million, falling short of analysts’ expectations of $253.5 million.
On March 4, 2026, Cross Country Healthcare reported its latest quarterly earnings, revealing a loss of $0.06 per share. This figure was notably lower than the analysts’ consensus estimate of a profit of $0.03, marking a significant miss of $0.09. The company generated revenue of $236.76 million for the quarter, which also did not meet the analysts’ forecast of $254.30 million.
Stock Performance and Market Insights
During trading on Wednesday, shares of Cross Country Healthcare saw a modest increase, rising by $0.15 to reach $9.13. The trading volume stood at 624,826 shares, surpassing the average volume of 536,784. Over the past year, the stock has fluctuated, with a low of $7.43 and a high of $17.02. Currently, the stock is trading below its fifty-day moving average of $8.60 and its two-hundred-day moving average of $10.78.
Cross Country Healthcare’s market capitalization stands at $299.10 million, with a price-to-earnings (P/E) ratio of -18.63 and a price-to-earnings-growth (PEG) ratio of 6.49. The company’s beta is 0.42, indicating lower volatility compared to the broader market.
Institutional Activity and Future Projections
Recent activity among institutional investors reflects a growing interest in Cross Country Healthcare. For instance, AllianceBernstein L.P. increased its holdings by 4.0% in the second quarter, owning 2,438,282 shares valued at $31.82 million after acquiring an additional 94,798 shares.
Similarly, Goldman Sachs Group Inc. boosted its stake by 56.9% in the first quarter, now holding 1,095,178 shares worth $16.31 million. Other notable institutional movements include Quinn Opportunity Partners LLC, which purchased a new position valued at $8.47 million, and Charles Schwab Investment Management Inc., which raised its position by 28.0%.
Currently, institutional investors and hedge funds control 96.03% of Cross Country Healthcare’s stock, reflecting a strong confidence in the company’s future despite the recent earnings guidance adjustments.
Cross Country Healthcare, based in Boca Raton, Florida, is a prominent provider of healthcare workforce solutions in the United States. The firm specializes in recruiting, placing, and managing nursing and allied health professionals, catering to a range of settings including hospitals and long-term care facilities. Its services encompass travel nurse staffing, per diem staffing, permanent placements, and managed services programs.
As Cross Country Healthcare navigates these financial adjustments, stakeholders will be keenly watching how the company adapts to market challenges and the broader economic landscape.
